Shares of Ensign Group fell 2.5% after earnings, reflecting investor caution despite stable occupancy and skilled mix growth, likely due to underlying concerns about margin pressures or a cautious outlook not fully offset by volume trends.
The Ensign Group reported a record quarter in Q3 2025, driven by strong clinical performance and growing occupancy rates, setting the stage for sustained long-term growth.